Literature DB >> 1917344

Airway obstruction in Hurler's syndrome--radiographic features.

C M Myer1.   

Abstract

The mucopolysaccharidosis (MPS) diseases are progressive clinical disorders which are characterized by a deficiency of lysosomal enzymes. In MPS I (Hurler's syndrome), reduced activity of alpha-L-iduronidase leads to intralysosomal storage of dermatan and heparan sulfate in various tissues. Airway obstruction is a frequent problem in these patients, often secondary to abnormal cervical vertebra, a short neck, a high epiglottis, and mucopolysaccharide infiltration of the soft tissues in the upper aerodigestive tract. Evaluation of these abnormalities may include plain film and videofluoroscopic examinations of the airway. The therapeutic and diagnostic implications of such studies are discussed in a review of 4 patients with Hurler's syndrome manifesting upper airway obstruction.

Entities:  

Mesh:

Year:  1991        PMID: 1917344     DOI: 10.1016/0165-5876(91)90101-g

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  3 in total

Review 1.  Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders.

Authors:  E I Parker; M Xing; A Moreno-De-Luca; E Harmouche; M R Terk
Journal:  Br J Radiol       Date:  2013-11-14       Impact factor: 3.039

Review 2.  Anaesthesia and airway management in mucopolysaccharidosis.

Authors:  Robert Walker; Kumar G Belani; Elizabeth A Braunlin; Iain A Bruce; Henrik Hack; Paul R Harmatz; Simon Jones; Richard Rowe; Guirish A Solanki; Barbara Valdemarsson
Journal:  J Inherit Metab Dis       Date:  2012-11-30       Impact factor: 4.982

Review 3.  Respiratory and sleep disorders in mucopolysaccharidosis.

Authors:  Kenneth I Berger; Simone C Fagondes; Roberto Giugliani; Karen A Hardy; Kuo Sheng Lee; Ciarán McArdle; Maurizio Scarpa; Martin J Tobin; Susan A Ward; David M Rapoport
Journal:  J Inherit Metab Dis       Date:  2012-11-15       Impact factor: 4.982

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.